444 related articles for article (PubMed ID: 17560140)
21. Bisphosphonate-related osteonecrosis of the jaw around dental implants in the maxilla: report of a case.
Shirota T; Nakamura A; Matsui Y; Hatori M; Nakamura M; Shintani S
Clin Oral Implants Res; 2009 Dec; 20(12):1402-8. PubMed ID: 19793318
[TBL] [Abstract][Full Text] [Related]
22. Bisphosphonate-related osteonecrosis of the jaws: a report of three cases demonstrating variability in outcomes and morbidity.
Kumar V; Pass B; Guttenberg SA; Ludlow J; Emery RW; Tyndall DA; Padilla RJ
J Am Dent Assoc; 2007 May; 138(5):602-9. PubMed ID: 17473037
[TBL] [Abstract][Full Text] [Related]
23. Osteonecrosis of the jaws in patients treated with bisphosphonates - histomorphologic analysis in comparison with infected osteoradionecrosis.
Hansen T; Kunkel M; Weber A; James Kirkpatrick C
J Oral Pathol Med; 2006 Mar; 35(3):155-60. PubMed ID: 16454811
[TBL] [Abstract][Full Text] [Related]
24. Osteonecrosis of the jaws in patients with a history of receiving bisphosphonate therapy: strategies for prevention and early recognition.
Melo MD; Obeid G
J Am Dent Assoc; 2005 Dec; 136(12):1675-81. PubMed ID: 16383049
[TBL] [Abstract][Full Text] [Related]
25. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment.
Marx RE; Sawatari Y; Fortin M; Broumand V
J Oral Maxillofac Surg; 2005 Nov; 63(11):1567-75. PubMed ID: 16243172
[TBL] [Abstract][Full Text] [Related]
26. Bisphosphonate-related osteonecrosis of the jaw and left thumb.
Longo R; Castellana MA; Gasparini G
J Clin Oncol; 2009 Dec; 27(35):e242-3. PubMed ID: 19858386
[No Abstract] [Full Text] [Related]
27. Dental and periodontal history of oncologic patients on parenteral bisphosphonates with or without osteonecrosis of the jaws: a pilot study.
Carmagnola D; Celestino S; Abati S
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Dec; 106(6):e10-5. PubMed ID: 18801674
[TBL] [Abstract][Full Text] [Related]
28. Involvement of the maxillary sinus in bisphosphonate-related osteonecrosis of the jaw: Radiologic aspects.
Wasserzug O; Kaffe I; Lazarovici TS; Weissman T; Yahalom R; Fliss DM; Yarom N
Am J Rhinol Allergy; 2017 Jan; 31(1):36-39. PubMed ID: 28234151
[TBL] [Abstract][Full Text] [Related]
29. Bisphosphonate-associated osteonecrosis of the jaws: a therapeutic dilemma.
Diego R; D'Orto O; Pagani D; Agazzi A; Marzano U; Derada Troletti G; Fontanella W; Pignataro L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):e1-5. PubMed ID: 17197204
[TBL] [Abstract][Full Text] [Related]
30. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases.
Grant BT; Amenedo C; Freeman K; Kraut RA
J Oral Maxillofac Surg; 2008 Feb; 66(2):223-30. PubMed ID: 18201600
[TBL] [Abstract][Full Text] [Related]
31. Sinus tracts--an early sign of bisphosphonate-associated osteonecrosis of the jaws?
Mawardi H; Treister N; Richardson P; Anderson K; Munshi N; Faiella RA; Woo SB
J Oral Maxillofac Surg; 2009 Mar; 67(3):593-601. PubMed ID: 19231786
[TBL] [Abstract][Full Text] [Related]
32. Bisphosphonate-associated Osteonecrosis of the jaws: a guide for the general dental practitioner.
Barker K; Rogers S
Dent Update; 2006 Jun; 33(5):270-2, 275. PubMed ID: 16841609
[TBL] [Abstract][Full Text] [Related]
33. Biphosphonate-induced osteonecrosis of the jaws: CT and MRI spectrum of findings in 32 patients.
Bisdas S; Chambron Pinho N; Smolarz A; Sader R; Vogl TJ; Mack MG
Clin Radiol; 2008 Jan; 63(1):71-7. PubMed ID: 18068792
[TBL] [Abstract][Full Text] [Related]
34. Association between osteonecrosis of the jaws and chronic high-dosage intravenous bisphosphonates therapy.
Graziani F; Cei S; La Ferla F; Cerri E; Itro A; Gabriele M
J Craniofac Surg; 2006 Sep; 17(5):876-9. PubMed ID: 17003614
[TBL] [Abstract][Full Text] [Related]
35. Biophosphonate-related osteonecrosis of the jaws.
Ruggiero SL; Woo SB
Dent Clin North Am; 2008 Jan; 52(1):111-28, ix. PubMed ID: 18154867
[TBL] [Abstract][Full Text] [Related]
36. Compromised osseous healing of dental extraction sites in zoledronic acid-treated dogs.
Allen MR; Kubek DJ; Burr DB; Ruggiero SL; Chu TM
Osteoporos Int; 2011 Feb; 22(2):693-702. PubMed ID: 20458574
[TBL] [Abstract][Full Text] [Related]
37. The phenomenon of osteonecrosis of the jaw in patients with metastatic breast cancer.
Van Poznak C
Cancer Invest; 2006 Feb; 24(1):110-2. PubMed ID: 16467002
[TBL] [Abstract][Full Text] [Related]
38. Bisphosphonates and jaw osteonecrosis in patients with advanced breast cancer.
Sanna G; Preda L; Bruschini R; Cossu Rocca M; Ferretti S; Adamoli L; Verri E; Franceschelli L; Goldhirsch A; Nolè F
Ann Oncol; 2006 Oct; 17(10):1512-6. PubMed ID: 16936182
[TBL] [Abstract][Full Text] [Related]
39. [Bisphosphonates and osteonecrosis of the jaw].
Schirmer I; Peters H; Reichart PA; Dürkop H
Mund Kiefer Gesichtschir; 2005 Jul; 9(4):239-45. PubMed ID: 15918066
[TBL] [Abstract][Full Text] [Related]
40. Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate.
Walter C; Al-Nawas B; Grötz KA; Thomas C; Thüroff JW; Zinser V; Gamm H; Beck J; Wagner W
Eur Urol; 2008 Nov; 54(5):1066-72. PubMed ID: 18602738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]